SYNGENE INTERNATIONAL
|
|
BOM : 539268     NSE : SYNGENE     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 20,2022 |
Price(EOD): ₹ 559.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Miscellaneous |
MCap: ₹ 22,444.28 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SYNGENE INTERNATIONAL | 4.8% | -10.7% | -7.1% |
QUESS CORP | 6.1% | 3.1% | -2% |
SUN PHARMA ADVANCED RESEARCH COMPANY | -0.8% | -18.7% | -2.4% |
TEAMLEASE SERVICES | -1.8% | -14.3% | 0.7% |
SECURITY AND INTELLIGENCE SERVICES INDIA | 1.3% | -4.1% | 20.5% |
JUST DIAL | 1.8% | -22.2% | -5.7% |
DELTA CORP | 3% | -18.8% | 43.2% |
HEALTHCARE GLOBAL ENTERPRISES | 4.7% | -6.9% | 42.9% |
VA TECH WABAG | 0.9% | -21.2% | -12.6% |
FUNDAMENTAL ANALYSIS OF SYNGENE INTERNATIONAL
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SYNGENE INTERNATIONAL
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
55.25
P/E Calculated based on EPS of 10.12
[ Mar2021 - Consolidated Results ] 8.15
P/B Calculated based on Book Value of 68.61
[ Mar2021 - Consolidated Results ] 8.62
P/S Calculated based on Revenues of 2604.2 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
37% 5% 5% |
SHARE PRICE MOMENTUM OF SYNGENE INTERNATIONAL
SYNGENE INTERNATIONAL vs SENSEX
DEBT OF SYNGENE INTERNATIONAL
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.28 0.32 0.41 0.34 |
0.28 0.32 0.41 0.34 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SYNGENE INTERNATIONAL
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SYNGENE INTERNATIONAL
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
18.19% 31.44% 39.49% 42.12% |
15.11% 14.48% -6.82% -7.97% |
QtrlyTrend |
4 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
SYNGENE INTERNATIONAL related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 4.1% | -8.7% | 16.8% |
S&P BSE MIDSMALLCAP | 3.7% | -8.4% | 12.6% |
S&P BSE 400 MIDSMALLCAP | 3.6% | -7.9% | 11.9% |
S&P BSE 150 MIDCAP | 3.3% | -7% | 11.5% |
S&P BSE ALLCAP | 3.2% | -5.8% | 10.3% |
S&P BSE 500 | 3.2% | -5.6% | 9.7% |
S&P BSE 250 LARGEMIDCAP | 3.1% | -5.3% | 9.5% |
S&P BSE 200 | 3.1% | -5.2% | 9.3% |
S&P BSE SMALLCAP SELECT INDEX | 3% | -7.4% | 12% |
S&P BSE HEALTHCARE | 2.8% | -6.4% | -4.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MID SMALL400 | 3.4% | -8% | 12.5% |
NIFTY500 MULTICAP 50:25:25 | 3.4% | -6.8% | 11% |
NIFTY 500 | 3.1% | -5.7% | 9.7% |
NIFTY HEALTHCARE | 3% | -6.2% | -3.4% |
NIFTY 200 | 3% | -5.3% | 9.3% |
NIFTY LARGE MIDCAP 250 | 3% | -6% | 10.5% |
NIFTY MIDCAP150 | 2.9% | -7.1% | 12% |
NIFTY FREE MIDCAP 100 | 2.9% | -7.3% | 12.3% |
You may also like the below Video Courses
FAQ about SYNGENE INTERNATIONAL
Is SYNGENE INTERNATIONAL good for long term investment?
As on May 20,2022, the Fundamentals of SYNGENE INTERNATIONAL look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of SYNGENE INTERNATIONAL . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SYNGENE INTERNATIONAL UnderValued or OverValued?
As on May 20,2022, SYNGENE INTERNATIONAL is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of SYNGENE INTERNATIONAL ?
As on May 20,2022, the Intrinsic Value of SYNGENE INTERNATIONAL is Rs. 530.00 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 406.82
Fair Value [Median EV / Sales Model] : Rs. 530.00
Fair Value [Median Price / Sales Model] : Rs. 532.45
Median Fair Value of SYNGENE INTERNATIONAL : Rs. 530.00
Is SYNGENE INTERNATIONAL trading at a Premium or Discount?
As on May 20,2022, SYNGENE INTERNATIONAL is trading at a Premium of 6% based on the estimates of Median Intrinsic Value!
Quarterly Results of QUESS CORP LTD Quarterly Results of SUN PHARMA ADVANCED RESEARCH COMPANY LTD Quarterly Results of TEAMLEASE SERVICES LTD Quarterly Results of SIS LTD |
SYNGENE INTERNATIONAL LTD vs QUESS CORP LTD vs SUN PHARMA ADVANCED RESEARCH COMPANY LTD
TEAMLEASE SERVICES LTD vs SIS LTD vs JUST DIAL LTD
DELTA CORP LTD vs HEALTHCARE GLOBAL ENTERPRISES LTD vs VA TECH WABAG LTD
BLS INTERNATIONAL SERVICES LTD vs SAFARI INDUSTRIES (INDIA) LTD vs EKI ENERGY SERVICES LTD
ANTONY WASTE HANDLING CELL LTD vs YAARII DIGITAL INTEGRATED SERVICES LTD vs SANGHVI MOVERS LTD
Market Cap of QUESS CORP LTD Market Cap of SUN PHARMA ADVANCED RESEARCH COMPANY LTD Market Cap of TEAMLEASE SERVICES LTD Market Cap of SIS LTD |
